The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review.
<h4>Background and objectives</h4>Economic evaluations provide information to aid the optimal utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) are remarkably high, which makes these agents an important target for economic evaluations. This sys...
Saved in:
| Main Authors: | Jaana T Joensuu, Saara Huoponen, Kalle J Aaltonen, Yrjö T Konttinen, Dan Nordström, Marja Blom |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0119683 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.
by: Kalle J Aaltonen, et al.
Published: (2012-01-01) -
A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases.
by: Saara Huoponen, et al.
Published: (2015-01-01) -
Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1β and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis.
by: Juri Olkkonen, et al.
Published: (2015-01-01) -
Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain
by: Ariel Beresniak, et al.
Published: (2011-01-01) -
Pharmacoeconomic analysis of using biological agents in the treatment of rheumatoid arthritis
by: I. I. Dyakov, et al.
Published: (2014-09-01)